With the appointment of the former Health Minister for the Canadian province of Ontario, Tony Clement, to the position of federal Minister for Health in the new Conser-vative government, critics of Canada's publicly-funded health care system sense an opportunity for change. Brett Skinner, Director of Health and Pharmaceutical Policy Research at the Vancouver, Canada-based Fraser Institute, has presented a shopping list of reforms from the free-market oriented think-tank. He warns that allowing Cana-dian Internet pharmacists to export drugs to the USA (Marketletters passim) runs the risk of causing shortages in Canada, given the size of the US market, a problem that will get worse if more US citizens buy Canadian.
Writing in the Canadian daily newspaper the National Post, Mr Skinner says: "the number of American consumers who would be legally eligible to buy cross-border drugs under these proposals is conservatively estimated to be almost 119 million, or nearly four times Canada's entire population of approximately 32 million."
Price control = profits for Internet pharmacists
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze